Cue Biopharma Inc. (CUE) NASDAQ
$1.64 0.09 (5.81%)
Market Cap: $75.40M
As of 05/15/24 04:00 PM EDT. Market closed.
Cue Biopharma Inc. (CUE)
NASDAQ
$1.64
0.09 (5.81%)
Market Cap: $75.40M
As of 05/15/24 04:00 PM EDT. Market closed.
Add to Portfolio
cue biopharma is an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders. we design biologics to engage and modulate the activity of disease-associated t cells in the patient’s body, offering significant therapeutic advantages while potentially ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Daniel Passeri
Full Time Employees
49
CEO Compensation (Base)
$345,000
CEO Compensation (Total)
$833,858
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Daniel Passeri
Full Time Employees
49
CEO Compensation (Base)
$345,000
CEO Compensation (Total)
$833,858
Address
21 Erie St, Massachusetts, Cambridge, 02139-4260.
PRICE CHART FOR CUE BIOPHARMA INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.61
Previous Close
$1.55
Days Range
$1.53 - $1.67
52 week range
$1.30 - $4.89
Volume
263,507
Avg. Volume (30 days)
338,999
Market Cap
$75.40M
Dividend Yield
-
P/E
(1.51)
Shares Outstanding
48,643,316
Open
$1.61
Previous Close
$1.55
Days Range
$1.53 - $1.67
52 week range
$1.30 - $4.89
Volume
263,507
Avg. Volume (30 days)
338,999
Market Cap
$75.40M
Dividend Yield
-
P/E
(1.51)
Shares Outstanding
48,643,316
FINANCIAL STATEMENTS FOR CUE BIOPHARMA INC
LOADING...
INSIDER TRANSACTIONS FOR CUE BIOPHARMA INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Suri Anish | PRESIDENT AND CSO | Aug 25, 2023 | Buy | $2.76 | 4,000 | 11,040 | 135,638 | Aug 29, 2023, 04:08 PM |
PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | Aug 14, 2023 | Buy | $2.86 | 3,000 | 8,580 | 134,578 | Aug 16, 2023, 04:07 PM |
Kiener Peter A | Director | Mar 23, 2023 | Option Exercise | $2.86 | 9,682 | 27,691 | 9,682 | Mar 27, 2023, 04:05 PM |
Kiener Peter A | Director | Mar 23, 2023 | Sale | $3.28 | 9,325 | 30,586 | 357 | Mar 27, 2023, 04:05 PM |
Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | Aug 22, 2022 | Option Exercise | $3.05 | 2,828 | 8,625 | 14,311 | Aug 23, 2022, 04:03 PM |
Gray Cameron | Director | Jun 14, 2022 | Option Exercise | $3.20 | 51,562 | 164,998 | 687,049 | Jun 16, 2022, 04:01 PM |
Gray Cameron | Director | Jun 14, 2022 | Option Exercise | $2.70 | 61,111 | 165,000 | 738,611 | Jun 16, 2022, 04:01 PM |
Morich Frank | Director | May 27, 2022 | Buy | $3.75 | 28,000 | 105,000 | 28,000 | May 31, 2022, 04:06 PM |
Fletcher Aaron G.L. | Director | May 24, 2022 | Buy | $3.34 | 55,000 | 183,700 | 940,000 | May 25, 2022, 09:09 AM |
Fletcher Aaron G.L. | Director | May 23, 2022 | Buy | $3.52 | 150,000 | 528,000 | 885,000 | May 25, 2022, 09:09 AM |
Suri Anish | PRESIDENT AND CSO | Mar 31, 2022 | Option Exercise | $4.88 | 7,068 | 34,492 | 103,638 | Apr 04, 2022, 05:31 PM |
PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | Mar 31, 2022 | Option Exercise | $4.88 | 32,122 | 156,755 | 141,578 | Apr 04, 2022, 05:29 PM |
Fletcher Aaron G.L. | Director | Mar 31, 2022 | Buy | $4.76 | 735,000 | 3,498,600 | 735,000 | Apr 04, 2022, 05:28 PM |
Kiener Peter A | Director | Nov 16, 2021 | Option Exercise | $2.86 | 1,361 | 3,892 | 1,361 | Nov 17, 2021, 05:00 PM |
Kiener Peter A | Director | Nov 15, 2021 | Option Exercise | $2.86 | 18,815 | 53,811 | 18,815 | Nov 17, 2021, 05:00 PM |
Kiener Peter A | Director | Nov 16, 2021 | Sale | $18.02 | 1,361 | 24,525 | 0 | Nov 17, 2021, 05:00 PM |
Kiener Peter A | Director | Nov 15, 2021 | Sale | $17.92 | 18,815 | 337,165 | 0 | Nov 17, 2021, 05:00 PM |
Suri Anish | President and CSO | Nov 15, 2021 | Option Exercise | $8.26 | 8,000 | 66,080 | 102,038 | Nov 17, 2021, 05:00 PM |
Suri Anish | President and CSO | Nov 15, 2021 | Sale | $18.05 | 8,000 | 144,400 | 94,038 | Nov 17, 2021, 05:00 PM |
Suri Anish | President and CSO | Nov 11, 2021 | Option Exercise | $6.42 | 20,000 | 128,400 | 114,038 | Nov 15, 2021, 05:00 PM |
Suri Anish | President and CSO | Nov 11, 2021 | Sale | $15.07 | 20,000 | 301,354 | 94,038 | Nov 15, 2021, 05:00 PM |
PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | Sep 30, 2021 | Option Exercise | $14.57 | 31,677 | 461,534 | 98,700 | Oct 08, 2021, 04:00 PM |
Suri Anish | PRESIDENT AND CSO | Oct 06, 2021 | Option Exercise | $12.97 | 14,134 | 183,318 | 94,038 | Oct 08, 2021, 04:00 PM |
Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | Oct 01, 2021 | Option Exercise | $7.50 | 1,251 | 9,383 | 11,723 | Oct 05, 2021, 07:21 PM |
Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | Oct 01, 2021 | Sale | $14.21 | 1,251 | 17,783 | 10,472 | Oct 05, 2021, 07:21 PM |
Suri Anish | PRESIDENT AND CSO | Sep 23, 2021 | Option Exercise | $6.42 | 20,000 | 128,400 | 94,838 | Sep 27, 2021, 04:30 PM |
Suri Anish | PRESIDENT AND CSO | Sep 23, 2021 | Sale | $15.23 | 20,000 | 304,646 | 74,838 | Sep 27, 2021, 04:30 PM |
PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | Sep 24, 2021 | Buy | $14.72 | 3,400 | 50,051 | 55,377 | Sep 27, 2021, 04:30 PM |
Pienta Kenneth | Chief Medical Officer | Mar 16, 2021 | Option Exercise | $5.00 | 439 | 2,195 | 2,439 | Mar 17, 2021, 04:00 PM |
Pienta Kenneth | Chief Medical Officer | Mar 15, 2021 | Option Exercise | $5.00 | 13,000 | 65,000 | 15,000 | Mar 17, 2021, 04:00 PM |
Pienta Kenneth | Chief Medical Officer | Mar 16, 2021 | Sale | $15.09 | 439 | 6,626 | 2,000 | Mar 17, 2021, 04:00 PM |
Pienta Kenneth | Chief Medical Officer | Mar 15, 2021 | Sale | $15.10 | 13,000 | 196,269 | 2,000 | Mar 17, 2021, 04:00 PM |
Pienta Kenneth | Chief Medical Officer | Feb 16, 2021 | Option Exercise | $2.86 | 16,000 | 45,760 | 18,000 | Feb 18, 2021, 08:44 PM |
Pienta Kenneth | Chief Medical Officer | Feb 17, 2021 | Option Exercise | $4.36 | 4,274 | 18,631 | 6,274 | Feb 18, 2021, 08:44 PM |
Pienta Kenneth | Chief Medical Officer | Feb 16, 2021 | Sale | $15.15 | 16,000 | 242,422 | 2,000 | Feb 18, 2021, 08:44 PM |
Pienta Kenneth | Chief Medical Officer | Feb 17, 2021 | Sale | $15.06 | 4,274 | 64,345 | 2,000 | Feb 18, 2021, 08:44 PM |
Pienta Kenneth | Chief Medical Officer | Jan 20, 2021 | Option Exercise | $2.86 | 2,720 | 7,779 | 4,720 | Feb 18, 2021, 08:40 PM |
Pienta Kenneth | Chief Medical Officer | Jan 20, 2021 | Sale | $15.07 | 2,720 | 40,980 | 2,000 | Feb 18, 2021, 08:40 PM |
Pienta Kenneth | Chief Medical Officer | Jan 20, 2021 | Buy | $15.07 | 2,720 | 40,980 | 4,720 | Jan 22, 2021, 04:33 PM |
Fletcher Aaron G.L. | Director | Nov 24, 2020 | Buy | $12.64 | 6,548 | 82,776 | 165,000 | Nov 25, 2020, 04:09 PM |
Suri Anish | President and CSO | Oct 05, 2020 | Option Exercise | $16.30 | 9,800 | 159,740 | 58,091 | Oct 06, 2020, 05:08 PM |
Gray Cameron | Director | Sep 30, 2020 | Buy | $15.30 | 5,000 | 76,500 | 677,500 | Oct 01, 2020, 04:13 PM |
Gray Cameron | Director | Sep 29, 2020 | Buy | $15.00 | 5,000 | 75,000 | 672,500 | Oct 01, 2020, 04:13 PM |
Sandercock Colin | SVP, General Counsel and Sec | Aug 05, 2020 | Option Exercise | $7.50 | 13,374 | 100,305 | 30,499 | Aug 10, 2020, 04:03 PM |
Sandercock Colin | SVP, General Counsel and Sec | Aug 05, 2020 | Sale | $20.00 | 13,374 | 267,480 | 17,125 | Aug 10, 2020, 04:03 PM |
Sandercock Colin | SVP, General Counsel and Sec | Aug 05, 2020 | Option Exercise | $7.50 | 13,274 | 99,555 | 30,399 | Aug 07, 2020, 05:44 PM |
Sandercock Colin | SVP, General Counsel and Sec | Aug 05, 2020 | Sale | $20.00 | 13,274 | 265,480 | 17,125 | Aug 07, 2020, 05:44 PM |
Suri Anish | President and CSO | Aug 05, 2020 | Option Exercise | $6.42 | 800 | 5,136 | 35,358 | Aug 07, 2020, 05:41 PM |
Suri Anish | President and CSO | Aug 05, 2020 | Sale | $20.01 | 800 | 16,008 | 34,558 | Aug 07, 2020, 05:41 PM |
Sandercock Colin | SVP, General Counsel and Sec | Aug 04, 2020 | Option Exercise | $7.50 | 201 | 1,508 | 17,326 | Aug 05, 2020, 04:51 PM |
Sandercock Colin | SVP, General Counsel and Sec | Aug 03, 2020 | Option Exercise | $7.50 | 6,425 | 48,188 | 23,550 | Aug 05, 2020, 04:51 PM |
Sandercock Colin | SVP, General Counsel and Sec | Aug 04, 2020 | Sale | $20.05 | 201 | 4,030 | 17,125 | Aug 05, 2020, 04:51 PM |
Sandercock Colin | SVP, General Counsel and Sec | Aug 03, 2020 | Sale | $20.00 | 6,425 | 128,500 | 17,125 | Aug 05, 2020, 04:51 PM |
Suri Anish | President and CSO | Aug 04, 2020 | Option Exercise | $6.42 | 400 | 2,568 | 34,958 | Aug 05, 2020, 04:50 PM |
Suri Anish | President and CSO | Aug 03, 2020 | Option Exercise | $7.05 | 5,800 | 40,916 | 40,358 | Aug 05, 2020, 04:50 PM |
Suri Anish | President and CSO | Aug 04, 2020 | Sale | $20.14 | 400 | 8,056 | 34,558 | Aug 05, 2020, 04:50 PM |
Suri Anish | President and CSO | Aug 03, 2020 | Sale | $20.01 | 5,800 | 116,058 | 34,558 | Aug 05, 2020, 04:50 PM |
Fletcher Aaron G.L. | Director | Jun 24, 2020 | Buy | $24.88 | 7,500 | 186,572 | 158,452 | Jun 25, 2020, 04:01 PM |
Sandercock Colin | SVP, General Counsel and Sec | Jun 10, 2019 | Buy | $7.90 | 15,025 | 118,698 | 17,125 | Feb 24, 2020, 04:56 PM |
Sandercock Colin | SVP, General Counsel and Sec | Jun 07, 2019 | Buy | $7.35 | 100 | 735 | 2,100 | Feb 24, 2020, 04:56 PM |
MARLETT CHRISTOPHER A | Director | Dec 31, 2019 | Sale | $15.71 | 9,000 | 141,390 | 0 | Dec 31, 2019, 06:26 PM |
MARLETT CHRISTOPHER A | Director | Dec 31, 2019 | Sale | $15.77 | 6,700 | 105,659 | 768,503 | Dec 31, 2019, 06:26 PM |
MARLETT CHRISTOPHER A | Director | Dec 27, 2019 | Sale | $17.24 | 9,000 | 155,160 | 775,203 | Dec 31, 2019, 06:26 PM |
MARLETT CHRISTOPHER A | Director | Dec 26, 2019 | Sale | $17.53 | 19,647 | 344,412 | 784,203 | Dec 27, 2019, 04:39 PM |
MARLETT CHRISTOPHER A | Director | Dec 23, 2019 | Sale | $16.82 | 17,000 | 285,940 | 803,850 | Dec 27, 2019, 04:39 PM |
MARLETT CHRISTOPHER A | Director | Dec 17, 2019 | Sale | $15.73 | 20,732 | 326,114 | 824,850 | Dec 19, 2019, 05:35 PM |
MARLETT CHRISTOPHER A | Director | Dec 19, 2019 | Sale | $17.00 | 4,000 | 68,000 | 820,850 | Dec 19, 2019, 05:35 PM |
Suri Anish | President and CSO | Nov 01, 2019 | Option Exercise | $8.63 | 12,087 | 104,311 | 23,246 | Nov 04, 2019, 05:34 PM |
PASSERI DANIEL R | CEO and President | Jun 21, 2019 | Buy | $7.26 | 1,377 | 9,997 | 51,977 | Jun 25, 2019, 04:09 PM |
Sandercock Colin | SVP, General Counsel and Sec | Jun 10, 2019 | Buy | $7.93 | 14,938 | 118,458 | 16,938 | Jun 10, 2019, 06:16 PM |
Sandercock Colin | SVP, General Counsel and Sec | Jun 06, 2019 | Buy | $7.10 | 2,000 | 14,200 | 2,000 | Jun 10, 2019, 06:16 PM |
PASSERI DANIEL R | CEO and President | Jun 06, 2019 | Buy | $6.90 | 3,000 | 20,700 | 50,600 | Jun 07, 2019, 04:12 PM |
DIGIANDOMENICO ANTHONY | Director | Dec 24, 2018 | Buy | $4.81 | 10,000 | 48,100 | 30,000 | Jan 04, 2019, 06:21 PM |
MARLETT CHRISTOPHER A | Director | Dec 31, 2018 | Buy | $4.64 | 18,521 | 85,937 | 89,602 | Jan 02, 2019, 04:20 PM |
DIGIANDOMENICO ANTHONY | Director | Dec 28, 2018 | Buy | $4.62 | 7,000 | 32,340 | 57,000 | Jan 02, 2019, 04:18 PM |
DIGIANDOMENICO ANTHONY | Director | Dec 27, 2018 | Buy | $4.77 | 20,000 | 95,400 | 50,000 | Dec 28, 2018, 08:40 AM |
MARLETT CHRISTOPHER A | Director | Dec 26, 2018 | Buy | $4.29 | 19,647 | 84,286 | 71,081 | Dec 27, 2018, 04:28 PM |
Suri Anish | Chief Scientific Officer | Dec 21, 2018 | Buy | $4.37 | 2,000 | 8,740 | 2,000 | Dec 26, 2018, 06:25 PM |
MARLETT CHRISTOPHER A | Director | Dec 21, 2018 | Buy | $4.53 | 17,200 | 77,916 | 51,434 | Dec 26, 2018, 04:09 PM |
DIGIANDOMENICO ANTHONY | Director | Dec 21, 2018 | Buy | $4.49 | 10,000 | 44,900 | 20,000 | Dec 26, 2018, 04:07 PM |
MARLETT CHRISTOPHER A | Director | Dec 20, 2018 | Buy | $4.74 | 9,438 | 44,736 | 34,234 | Dec 21, 2018, 07:22 AM |
MARLETT CHRISTOPHER A | Director | Dec 19, 2018 | Buy | $5.00 | 400 | 2,000 | 24,796 | Dec 20, 2018, 04:17 PM |
MARLETT CHRISTOPHER A | Director | Dec 18, 2018 | Buy | $5.20 | 3,664 | 19,053 | 24,396 | Dec 19, 2018, 07:39 AM |
DIGIANDOMENICO ANTHONY | Director | Dec 17, 2018 | Buy | $5.48 | 10,000 | 54,800 | 10,000 | Dec 18, 2018, 04:31 PM |
MARLETT CHRISTOPHER A | Director | Dec 13, 2018 | Buy | $5.06 | 10,000 | 50,600 | 20,732 | Dec 17, 2018, 07:47 AM |
MARLETT CHRISTOPHER A | Director | Dec 12, 2018 | Buy | $5.07 | 3,189 | 16,168 | 10,732 | Dec 13, 2018, 04:51 PM |
MARLETT CHRISTOPHER A | Director | Dec 12, 2018 | Buy | $5.09 | 9,000 | 45,810 | 9,000 | Dec 13, 2018, 04:51 PM |
MARLETT CHRISTOPHER A | Director | Dec 11, 2018 | Buy | $4.86 | 7,543 | 36,659 | 7,543 | Dec 12, 2018, 05:51 PM |
Millar Kerri-Ann | VP-Finance | Aug 29, 2018 | Buy | $8.48 | 1,000 | 8,480 | 1,000 | Aug 29, 2018, 06:39 PM |
PASSERI DANIEL R | CEO and President | Aug 16, 2018 | Buy | $8.09 | 6,000 | 48,510 | 47,600 | Aug 20, 2018, 04:08 PM |
PASSERI DANIEL R | CEO and President | Jun 29, 2018 | Buy | $11.97 | 1,600 | 19,152 | 41,600 | Jun 29, 2018, 04:10 PM |
Pienta Kenneth | Chief Medical Officer | Dec 27, 2017 | Buy | $7.50 | 2,000 | 15,000 | 2,000 | Jan 19, 2018, 05:03 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Suri Anish | PRESIDENT AND CSO | 08/25/2023 | 11,040 |
PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | 08/14/2023 | 8,580 |
Kiener Peter A | Director | 03/23/2023 | 27,691 |
Kiener Peter A | Director | 03/23/2023 | 30,586 |
Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | 08/22/2022 | 8,625 |
Gray Cameron | Director | 06/14/2022 | 164,998 |
Gray Cameron | Director | 06/14/2022 | 165,000 |
Morich Frank | Director | 05/27/2022 | 105,000 |
Fletcher Aaron G.L. | Director | 05/24/2022 | 183,700 |
Fletcher Aaron G.L. | Director | 05/23/2022 | 528,000 |
Suri Anish | PRESIDENT AND CSO | 03/31/2022 | 34,492 |
PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | 03/31/2022 | 156,755 |
Fletcher Aaron G.L. | Director | 03/31/2022 | 3,498,600 |
Kiener Peter A | Director | 11/16/2021 | 3,892 |
Kiener Peter A | Director | 11/15/2021 | 53,811 |
Kiener Peter A | Director | 11/16/2021 | 24,525 |
Kiener Peter A | Director | 11/15/2021 | 337,165 |
Suri Anish | President and CSO | 11/15/2021 | 66,080 |
Suri Anish | President and CSO | 11/15/2021 | 144,400 |
Suri Anish | President and CSO | 11/11/2021 | 128,400 |
Suri Anish | President and CSO | 11/11/2021 | 301,354 |
PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | 09/30/2021 | 461,534 |
Suri Anish | PRESIDENT AND CSO | 10/06/2021 | 183,318 |
Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | 10/01/2021 | 9,383 |
Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | 10/01/2021 | 17,783 |
Suri Anish | PRESIDENT AND CSO | 09/23/2021 | 128,400 |
Suri Anish | PRESIDENT AND CSO | 09/23/2021 | 304,646 |
PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | 09/24/2021 | 50,051 |
Pienta Kenneth | Chief Medical Officer | 03/16/2021 | 2,195 |
Pienta Kenneth | Chief Medical Officer | 03/15/2021 | 65,000 |
Pienta Kenneth | Chief Medical Officer | 03/16/2021 | 6,626 |
Pienta Kenneth | Chief Medical Officer | 03/15/2021 | 196,269 |
Pienta Kenneth | Chief Medical Officer | 02/16/2021 | 45,760 |
Pienta Kenneth | Chief Medical Officer | 02/17/2021 | 18,631 |
Pienta Kenneth | Chief Medical Officer | 02/16/2021 | 242,422 |
Pienta Kenneth | Chief Medical Officer | 02/17/2021 | 64,345 |
Pienta Kenneth | Chief Medical Officer | 01/20/2021 | 7,779 |
Pienta Kenneth | Chief Medical Officer | 01/20/2021 | 40,980 |
Pienta Kenneth | Chief Medical Officer | 01/20/2021 | 40,980 |
Fletcher Aaron G.L. | Director | 11/24/2020 | 82,776 |
Suri Anish | President and CSO | 10/05/2020 | 159,740 |
Gray Cameron | Director | 09/30/2020 | 76,500 |
Gray Cameron | Director | 09/29/2020 | 75,000 |
Sandercock Colin | SVP, General Counsel and Sec | 08/05/2020 | 100,305 |
Sandercock Colin | SVP, General Counsel and Sec | 08/05/2020 | 267,480 |
Sandercock Colin | SVP, General Counsel and Sec | 08/05/2020 | 99,555 |
Sandercock Colin | SVP, General Counsel and Sec | 08/05/2020 | 265,480 |
Suri Anish | President and CSO | 08/05/2020 | 5,136 |
Suri Anish | President and CSO | 08/05/2020 | 16,008 |
Sandercock Colin | SVP, General Counsel and Sec | 08/04/2020 | 1,508 |
Sandercock Colin | SVP, General Counsel and Sec | 08/03/2020 | 48,188 |
Sandercock Colin | SVP, General Counsel and Sec | 08/04/2020 | 4,030 |
Sandercock Colin | SVP, General Counsel and Sec | 08/03/2020 | 128,500 |
Suri Anish | President and CSO | 08/04/2020 | 2,568 |
Suri Anish | President and CSO | 08/03/2020 | 40,916 |
Suri Anish | President and CSO | 08/04/2020 | 8,056 |
Suri Anish | President and CSO | 08/03/2020 | 116,058 |
Fletcher Aaron G.L. | Director | 06/24/2020 | 186,572 |
Sandercock Colin | SVP, General Counsel and Sec | 06/10/2019 | 118,698 |
Sandercock Colin | SVP, General Counsel and Sec | 06/07/2019 | 735 |
MARLETT CHRISTOPHER A | Director | 12/31/2019 | 141,390 |
MARLETT CHRISTOPHER A | Director | 12/31/2019 | 105,659 |
MARLETT CHRISTOPHER A | Director | 12/27/2019 | 155,160 |
MARLETT CHRISTOPHER A | Director | 12/26/2019 | 344,412 |
MARLETT CHRISTOPHER A | Director | 12/23/2019 | 285,940 |
MARLETT CHRISTOPHER A | Director | 12/17/2019 | 326,114 |
MARLETT CHRISTOPHER A | Director | 12/19/2019 | 68,000 |
Suri Anish | President and CSO | 11/01/2019 | 104,311 |
PASSERI DANIEL R | CEO and President | 06/21/2019 | 9,997 |
Sandercock Colin | SVP, General Counsel and Sec | 06/10/2019 | 118,458 |
Sandercock Colin | SVP, General Counsel and Sec | 06/06/2019 | 14,200 |
PASSERI DANIEL R | CEO and President | 06/06/2019 | 20,700 |
DIGIANDOMENICO ANTHONY | Director | 12/24/2018 | 48,100 |
MARLETT CHRISTOPHER A | Director | 12/31/2018 | 85,937 |
DIGIANDOMENICO ANTHONY | Director | 12/28/2018 | 32,340 |
DIGIANDOMENICO ANTHONY | Director | 12/27/2018 | 95,400 |
MARLETT CHRISTOPHER A | Director | 12/26/2018 | 84,286 |
Suri Anish | Chief Scientific Officer | 12/21/2018 | 8,740 |
MARLETT CHRISTOPHER A | Director | 12/21/2018 | 77,916 |
DIGIANDOMENICO ANTHONY | Director | 12/21/2018 | 44,900 |
MARLETT CHRISTOPHER A | Director | 12/20/2018 | 44,736 |
MARLETT CHRISTOPHER A | Director | 12/19/2018 | 2,000 |
MARLETT CHRISTOPHER A | Director | 12/18/2018 | 19,053 |
DIGIANDOMENICO ANTHONY | Director | 12/17/2018 | 54,800 |
MARLETT CHRISTOPHER A | Director | 12/13/2018 | 50,600 |
MARLETT CHRISTOPHER A | Director | 12/12/2018 | 16,168 |
MARLETT CHRISTOPHER A | Director | 12/12/2018 | 45,810 |
MARLETT CHRISTOPHER A | Director | 12/11/2018 | 36,659 |
Millar Kerri-Ann | VP-Finance | 08/29/2018 | 8,480 |
PASSERI DANIEL R | CEO and President | 08/16/2018 | 48,510 |
PASSERI DANIEL R | CEO and President | 06/29/2018 | 19,152 |
Pienta Kenneth | Chief Medical Officer | 12/27/2017 | 15,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN CUE BIOPHARMA INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 2,244,103 | 0.0001% | -4.05% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 838,531 | 0.00015% | 3.1% | Other |
RENAISSANCE TECHNOLOGIES LLC | 274,033 | 0.00081% | 214.26% | Other |
AQR CAPITAL MANAGEMENT LLC | 22,340 | 0.00011% | Exited | Other |
CHANGE IN SHARES OUTSTANDING FOR CUE BIOPHARMA INC
STOCK BUYBACKS FOR CUE BIOPHARMA INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
4.81%
1Q
09/30/2023
6.70%
2Q
06/30/2023
10.42%
3Q
03/31/2023
10.78%
4Q
12/31/2022
26.25%
5Q
09/30/2022
39.80%
6Q
06/30/2022
39.91%
7Q
03/31/2022
51.57%
8Q
12/31/2021
54.84%
9Q
09/30/2021
57.96%
10Q
06/30/2021
58.38%
11Q
03/31/2021
62.53%
12Q
12/31/2020
63.25%
13Q
09/30/2020
66.83%
14Q
06/30/2020
75.28%
15Q
03/31/2020
86.18%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CUE BIOPHARMA INC
LOADING...